Gastrointestinal motility causes movement of food during digestion through contractions of the gut smooth muscle. The enteric nervous system regulates these events, and Muller et al. now find that its interaction with the immune system, in concert with gut microbiota, provides an additional layer of regulation to this complex task.
The gastrointestinal (GI) tract takes in large food particles, digests them to small-molecule components, absorbs the resulting nutrients in specialized compartments along the length of the tract, and eventually excretes the unwanted byproducts. It also houses commensal bacteria, which contribute to host metabolism, immunoregulation, and pathogen protection (Clemente et al., 2012) . At the heart of the GI tract's function are its intrinsic peristaltic movements, which facilitate proper anterograde propulsion of luminal contents. Richly innervated by the enteric nervous system (ENS), the gut senses food-induced stretch, as well as changes in luminal chemistry. This information is relayed to intrinsic interneurons, causing ascending excitatory and descending inhibitory neurotransmission from the myenteric plexus, resulting in a wave of smooth muscle contraction behind the food bolus and relaxation in front of it. These signals act through pacemaker cells, called the interstitial cells of Cajal (ICC), predominantly onto the inner circular muscle layer of the muscularis externa (Kunze and Furness, 1999) . In this issue of Cell, Muller et al. (2014) discover another layer of complexity, revealing that, under homeostatic conditions, proper gastrointestinal motility relies on interactions between the ENS and the microbiome, with a tissue-resident population of muscularis macrophages (MMs) at the crossroads.
MMs are one subset of a widely heterogeneous group of macrophages that reside in tissue and contribute to normal development, in addition to providing trophic support and acting as immune sentinels (Wynn et al., 2013) (Figure 1 ). Located in discrete sheets in the muscularis externa, MM had previously been implicated in the pathogenesis of postoperative ileus, a temporary surgical complication resulting in intestinal paralysis due to peristaltic failure (Mikkelsen, 2010; Matteoli et al., 2014) . Although MM were known to be in close apposition to the myenteric plexus and ICC, nothing was known about the functional role of MM under normal physiological conditions or whether there was homeostatic crosstalk between ENS neurons and MM (Mikkelsen, 2010) . Muller et al. (2014) show that MM are a uniform population of CX3CR1 + CD11c lo MHCII hi cells, exquisitely dependent on the cytokine receptor CSF-1R, as demonstrated by their almost complete loss in CSFR1 -/-mice. The authors took advantage of this reliance by using a single, low-dose intraperitoneal injection of a blocking anti-CSF-1R antibody to specifically deplete 80% of MMs for 1 week, while leaving other GI resident macrophage populations and stromal cells intact. During MM depletion, mice displayed accelerated gastric emptying and reduced colonic emptying, and in vitro experiments showed deregulated, hyperreactive stretch-induced contractions of the muscularis externa, demonstrating a homeostatic role for MMs in the regulation of peristalsis. To discern the molecular mechanism underlying these effects, the authors analyzed secreted, nonimmune transcripts of MMs, finding a preferential expression of bone morphogenetic protein 2 (BMP2) (Figure 1) , a soluble protein known to engage the BMP receptors I and II (BMPRI and BMPRII). Given that BMPRI and BMPRII had been implicated in neuronal and smooth muscle development, BMP2 was a likely candidate for MM-mediated control of peristalsis. Supporting this, the BMP2 inhibitor dorsomorphin phenocopied MM depletion, whereas recombinant BMP2 rescued the phenotype.
As one hypothesis in the field proposed that MMs engage in crosstalk with ICC during ileus (Mikkelsen, 2010) , Muller et al. (2014) asked where BMP2 acts in the steady-state GI tract. Surprisingly, they found that BMPRII is expressed in enteric neurons (Figure 1 ), but not in ICC or enteric glia. Moreover, enteric neurons exhibited constitutive activation of SMAD1, SMAD5, and SMAD8, the downstream signaling mediators of BMP receptors, that was dependent on the presence of MMs, suggesting that MMs impact enteric neurons through secretion of BMP2. Because MMs depended on CSF-1R signaling, Muller et al. (2014) next asked what the ligand is for CSF-1R and its source. CSF-1R has two ligands, CSF-1 and IL-34. Whereas multiple cell types produce CSF-1, neuroepithelial cells selectively produce IL-34. Remarkably, enteric neurons were found to produce CSF-1 (Figure 1 ), further suggesting a crosstalk with MMs. Accordingly, mice with an inactivating mutation of CSF-1 (Csf1 op / op ) show decreased SMAD activation and signs of GI dysmotility.
Many studies have established that the intestinal microbiota educates mucosal immune cells, including macrophages, which, in turn, influence the ecology of the microflora (Clemente et al., 2012) . Germ-free mice and mice treated with antibiotics are also known to have GI dysmotility. But could the intestinal microbiota influence the function of MMs despite the distance between the intestinal lumen and MMs? After treating mice with antibiotics, Muller et al. (2014) found decreased BMP2, decreased CSF1, and decreased numbers of MMs in conjunction with GI dysmotility. In vitro culture of enteric neurons with the bacterial product LPS resulted in enhanced production of CSF1, and supplementing the diet of germ-free mice with LPS reconstituted CSF1 and MM numbers and partially improved GI transit time, though a fecal transplant was necessary for complete rescue. These results demonstrated that the intestinal microbiota control GI peristalsis at least in part through ENS-MM crosstalk.
Although crosstalk between the nervous and immune system during inflammation has been well studied, particularly in work pioneered by Kevin Tracey and colleagues (Olofsson et al., 2012) , these findings advance our understanding of the importance of bidirectional neuroimmune communication for homeostatic physiological functions. Immune cells, particularly macrophages, produce neurotropic factors such as BDNF (Parkhurst et al., 2013) , and the authors here identify BMP2 as another neurotrophic factor produced by macrophages. However, the question remains how BMP2 modulates ENS activity downstream of SMAD activation. Does it regulate neurotransmitter production or release or alter electrophysiology and action potential conduction? Finally, perhaps the most important outcome of this study is the identification of the intestinal microbiota as a novel component in the neuroimmune crosstalk, with MMs acting as intermediaries between the microflora and the ENS. This observation raises multiple questions, such as how microbial components reach MMs, whether LPS is the main product that elicits ENS-MM crosstalk, or whether multiple microbial products and sensors are implicated.
Like the heartbeat, GI motility is necessary for life, as infants with Hirschsprung's disease who have congenital defects in the distal ENS development and are unable to pass excretory products die in the first days of life without surgical correction (Sasselli et al., 2012) . Later in life, functional bowel disorders including irritable bowel syndrome (IBS) are prevalent and cause substantial morbidity and heath care costs but are relatively understudied (Talley, 2008) . Better understanding of neuroimmune crosstalk following the exciting results by Muller et al. (2014) may open new avenues of therapeutic intervention in disorders of the GI motility. The presence of bacterial products, including LPS, causes enteric neurons to produce CSF1, which binds to the CSF-1R on CX3CR1 + CD11c lo MHCII hi MMs and promotes their maintenance. MMs produce BMP2, which binds to the BMP receptor, composed of BMPRI and BMPRII, the latter of which is expressed on axons in the myenteric plexus, but not in ICC or enteric glia. Through a yet-undefined mechanism, BMP2 binding to enteric neurons regulates intestinal motility. Submucosal neural plexus and additional ICC layers are excluded for simplicity.
